Literature DB >> 20798165

Diversity of caecal bacteria is altered in interleukin-10 gene-deficient mice before and after colitis onset and when fed polyunsaturated fatty acids.

Bianca Knoch1, Katia Nones, Matthew P G Barnett, Warren C McNabb, Nicole C Roy.   

Abstract

Interleukin-10 gene-deficient (Il10(-/-)) mice show a hyper-reaction to normal intestinal bacteria and develop spontaneous colitis similar to that of human Crohn's disease when raised under conventional (but not germ-free) conditions. The lack of IL10 protein in these mice leads to changes in intestinal metabolic and signalling processes. The first aim of this study was to identify changes in the bacterial community of the caeca at 7 weeks of age (preclinical colitis) and at 12 weeks of age (when clinical signs of colitis are present), and establish if there were any changes that could be associated with the mouse genotype. We have previously shown that dietary n-3 and n-6 polyunsaturated fatty acids (PUFA) have anti-inflammatory effects and affect colonic gene expression profiles in Il10(-/-) mice; therefore, we also aimed to test the effect of the n-3 PUFA eicosapentaenoic acid (EPA) and the n-6 PUFA arachidonic acid (AA) on the bacterial community of caeca in both Il10(-/-) and C57 mice fed these diets. The lower number of caecal bacteria observed before colitis (7 weeks of age) in Il10(-/-) compared to C57 mice suggests differences in the intestinal bacteria that might be associated with the genotype, and this could contribute to the development of colitis in this mouse model. The number and diversity of caecal bacteria increased after the onset of colitis (12 weeks of age). The increase in caecal Escherichia coli numbers in both inflamed Il10(-/-) and healthy C57 mice might be attributed to the dietary PUFA (especially dietary AA), and thus not be a cause of colitis development. A possible protective effect of E. coli mediated by PUFA supplementation and associated changes in the bacterial environment could be a subject for further investigation to define the mode of action of PUFA in colitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798165     DOI: 10.1099/mic.0.041723-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  6 in total

1.  Human gut microbiome and risk for colorectal cancer.

Authors:  Jiyoung Ahn; Rashmi Sinha; Zhiheng Pei; Christine Dominianni; Jing Wu; Jianxin Shi; James J Goedert; Richard B Hayes; Liying Yang
Journal:  J Natl Cancer Inst       Date:  2013-12-06       Impact factor: 13.506

Review 2.  Diet as a Therapeutic Option for Adult Inflammatory Bowel Disease.

Authors:  Samir Kakodkar; Ece A Mutlu
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 3.  Potential value of nutrigenomics in Crohn's disease.

Authors:  Lynnette R Ferguson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-13       Impact factor: 46.802

Review 4.  A Multihit Model: Colitis Lessons from the Interleukin-10-deficient Mouse.

Authors:  Lydia M Keubler; Manuela Buettner; Christine Häger; André Bleich
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

5.  Temporal Dynamics of Chronic Inflammation on the Cecal Microbiota in IL-10-/- Mice.

Authors:  Anne-Marie C Overstreet; Amanda E Ramer-Tait; Jan S Suchodolski; Jesse M Hostetter; Chong Wang; Albert E Jergens; Gregory J Phillips; Michael J Wannemuehler
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

6.  Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species.

Authors:  Shalome A Bassett; Wayne Young; Matthew P G Barnett; Adrian L Cookson; Warren C McNabb; Nicole C Roy
Journal:  Nutrients       Date:  2015-03-11       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.